Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,410 | 12,201 | 17,417 | 11,911 | 15,912 |
| TOTAL | $15,865 | $12,698 | $17,902 | $12,176 | $16,353 |
| Non-Current Assets | |||||
| PPE Net | 1,374 | 1,408 | 1,470 | 1,544 | 1,534 |
| Other Non-Current Assets | 39 | 39 | 39 | 61 | 84 |
| TOTAL | $1,413 | $1,447 | $1,509 | $1,605 | $1,618 |
| Total Assets | $17,278 | $14,145 | $19,411 | $13,781 | $17,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 911 | 882 | 3,165 | 2,332 | 2,336 |
| Accrued Expenses | 1,137 | 1,005 | 1,260 | 1,018 | 769 |
| Other current liabilities | N/A | N/A | N/A | 117 | 315 |
| TOTAL | $2,048 | $1,887 | $4,425 | $3,467 | $3,420 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,053 | 5,194 | 5,176 | 12,840 | 17,189 |
| TOTAL | $5,862 | $5,999 | $5,979 | $13,640 | $17,986 |
| Total Liabilities | $7,910 | $7,886 | $10,404 | $17,107 | $21,406 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,315 | 5,671 | 5,671 | 2,944 | 2,943 |
| Common Shares | 8 | 28 | 5 | 15 | 15 |
| Retained earnings | -184,598 | -181,704 | -178,803 | -181,703 | -181,588 |
| TOTAL | $9,368 | $6,259 | $9,007 | $-3,326 | $-3,435 |
| Total Liabilities And Equity | $17,278 | $14,145 | $19,411 | $13,781 | $17,971 |